目标:Barleria,刺槐科的一个大属,由300多个物种组成,具有不同的分类学,细胞遗传学,植物化学和药理潜力。因此,这篇综述的目的是对Barleria的研究进行批判性评估,并为未来的研究提供指导.
方法:数据来自不同来源,比如书,theses,期刊和一些网站和基于互联网的搜索,1901年至2020年出版。从PubMed获得的数据,谷歌学者,ScienceDirect,在线电子期刊,SpringerLink,威利,等。也被使用过。
结果:该属的物种表现出相当大的药用特性。细胞遗传学数据很少,只有24个物种的染色体计数可用。最常见的染色体数为2n=2x=40。到目前为止,从Barleria物种报告了187种化合物。积极的原则,其用途,毒性和药理作用进行了讨论。精油,黄酮,黄酮类化合物,糖苷,萜烯和萜类化合物形成主要化合物。
结论:强烈建议利用Barleria物种的药理和经济潜力,并对其利用和保护进行更详细的研究和关注。此外,确保最大的药理益处和可持续使用,有必要有经验信息来解释其民族植物学价值以及商业潜力。
OBJECTIVE: Barleria, a large genus of the Acanthaceae family, comprises more than 300 species with diverse taxonomy, cytogenetics, phytochemistry and pharmacological potential. Therefore, the aim of this
review is to critically assess the research on Barleria and provide guidance for future investigations.
METHODS: The data were obtained from different sources, such as books, theses, journals and some of the websites and internet-based searches, published from 1901 to 2020. Data obtained from PubMed, Google Scholar, ScienceDirect, online electronic journals, SpringerLink, Wiley, etc. have also been used.
RESULTS: The species of this genus exhibit considerable medicinal properties. Cytogenetical data are scantily available with chromosome counts available for only 24 species. The most common chromosome number is 2n = 2x = 40. So far, 187 compounds are reported from Barleria species. The active principles, their uses, toxicity and pharmacological effects are discussed. Essential oils, flavones, flavonoids, glycosides, terpenes and terpenoids form the major compounds.
CONCLUSIONS: It is highly recommended that the pharmacological and economic potential of Barleria species should be exploited and more detailed studies and attention be geared towards its utilization and conservation. In addition, to ensure maximum pharmacological benefits and sustainable use, it is necessary to have empirical information explaining its ethnobotanical values as well as commercial potential.